MiniMed initiated with ‘Buy' rating by Bank of America on pipeline-driven growth outlook [Yahoo! Finance]
MiniMed Group, Inc. (MMED)
Company Research
Source: Yahoo! Finance
MiniMed Group (NASDAQ:MMED) has been initiated with a ‘Buy' rating by Bank of America, reflecting the view that the company is approaching a key inflection point following its recent separation from Medtronic. The analysts gave the company, which specializes in developing and manufacturing technology for diabetes management, a $27 price target, implying upside from current levels of about $14. The initiation is grounded in expectations that MiniMed's pipeline and scale can support accelerating growth over the next several years, with the firm suggesting that current valuation levels do not fully capture the company's longer-term revenue trajectory or free cash flow potential. MiniMed is positioned as a large-scale, fully integrated diabetes technology company offering both insulin pumps and continuous glucose monitoring systems, allowing it to target insulin-intensive patients with a comprehensive solution. This integrated model differentiates it from peers such as Insulet Corp
Show less
Read more
Impact Snapshot
Event Time:
MMED
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MMED alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MMED alerts
High impacting MiniMed Group, Inc. news events
Weekly update
A roundup of the hottest topics
MMED
News
- MiniMed to announce financial results for its fourth quarter and full fiscal year 2026PR Newswire
- MiniMed Group (MMED) was upgraded by Zacks Research to "hold".MarketBeat
- Is It Time To Revisit Minimed Group (MMED) After Recent Share Price Weakness? [Yahoo! Finance]Yahoo! Finance
- MiniMed Group (MMED) is now covered by Barclays PLC. They set an "overweight" rating and a $26.00 price target on the stock.MarketBeat
- MMED (MMED) is now covered by Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $20.00 price target on the stock.MarketBeat
MMED
Sec Filings
- 4/17/26 - Form 10-Q
- 3/27/26 - Form 4
- 3/27/26 - Form 8-K
- MMED's page on the SEC website